Skip to content

Clinical trials

Phase 2 Carcinoma, Transitional Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Phase 2 Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20151
20173
20181
20191
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
AbbVie1
Astellas Pharma Inc1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Jazz Pharmaceuticals1
National Cancer Center, Korea1
Pusan National University Yangsan Hospital1
Samsung Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell12
Urinary Bladder Neoplasms4
Ureteral Neoplasms3
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Endometrial Neoplasms1
Esophageal Neoplasms1
Kidney Neoplasms1
Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.